These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7050462)

  • 1. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
    Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
    Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
    Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
    Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
    Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
    Takasaki H; Shibata M
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
    Hayashi S; Yamada K
    Rinsho Ketsueki; 1979 Apr; 20(4):400-9. PubMed ID: 156270
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of measuring alpha2-plasmin inhibitor levels in kidney diseases].
    Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Mizuhara H; Kawai S; Kuratsuji T; Shimizu K
    Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1035-43. PubMed ID: 6668744
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
    Hayashi S; Yamada K
    Thromb Res; 1979; 16(3-4):393-400. PubMed ID: 92817
    [No Abstract]   [Full Text] [Related]  

  • 8. alpha 2-plasmin inhibitor levels in relation to modes of urokinase administration.
    Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
    Thromb Res; 1980 Jul 1-15; 19(1-2):271-5. PubMed ID: 6449754
    [No Abstract]   [Full Text] [Related]  

  • 9. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
    Brochier M; Griguer P
    Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-urokinase treatment in aseptic dural sinus thrombosis.
    Di Rocco C; Iannelli A; Leone G; Moschini M; Valori VM
    Arch Neurol; 1981 Jul; 38(7):431-5. PubMed ID: 7018470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].
    Matsuo O; Mihara H
    Rinsho Ketsueki; 1977 Sep; 18(9):1097-101. PubMed ID: 592505
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparin therapy in various types of nephritis (author's transl)].
    Akagi K; Enomoto T; Mizutani O; Kobayashi N
    Nihon Jinzo Gakkai Shi; 1977 Nov; 19(11):849-69. PubMed ID: 609145
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membranoproliferative glomerulonephritis and allied glomerulonephritis: development, treatment and prognosis (author's transl)].
    Dohi K; Nakamoto Y; Kida H; Abe T; Fujioka M; Hattori N
    Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):195-207. PubMed ID: 6166777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
    Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
    Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of microangiopathic hemolytic anemia associated with pre-eclampsia (author's transl)].
    Ida T; Osaka Y; Tomura S; Ideura T; Abe T; Takeuchi J
    Rinsho Ketsueki; 1980 Aug; 21(8):1178-84. PubMed ID: 7441884
    [No Abstract]   [Full Text] [Related]  

  • 19. [Curative effects of low-dose heparin combined with urokinase on primary nephritic syndrome complicated by severe hypercoagulabale state in children].
    Fu Q; Zhou YL; Song XX; Wan SH; Mao LP; Hu JJ; Yu KG; Feng QH
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):921-2. PubMed ID: 22099206
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
    Oda T; Tamura K; Yoshizawa N; Sugisaki T; Matsumoto K; Hattori M; Sawai T; Namikoshi T; Yamada M; Kikuchi Y; Suzuki S; Miura S
    Nephrol Dial Transplant; 2008 Jul; 23(7):2254-9. PubMed ID: 18223261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.